METROPOLIS — Metropolis Healthcare Share Price
0.000.00%
Last trade - 00:00- IN₹89.12bn
- IN₹90.31bn
- IN₹11.48bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.52 | ||
| Price to Tang. Book | 41.48 | ||
| Price to Free Cashflow | 51.86 | ||
| Price to Sales | 7.69 | ||
| EV to EBITDA | 33.09 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.41% | ||
| Return on Equity | 12.46% | ||
| Operating Margin | 15.65% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 7,611.82 | 8,564.05 | 9,979.87 | 12,283.36 | 11,482.1 | n/a | n/a | 12.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +13.13 | +7.62 | +38.5 | +10.17 | -29.41 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 10th, 2000
- Public Since
- April 15th, 2019
- No. of Shareholders
- 87,293
- No. of Employees
- 4,289
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 51,228,806
- Address
- Nh-8, Sco No. 30, Sector 15, Part Ii, MUMBAI, 400018
- Web
- https://www.metropolisindia.com/
- Phone
- +91 8422801801
- Contact
- Ameera Shah
- Auditors
- BSR & Co. LLP
Upcoming Events for METROPOLIS
Q1 2025 Metropolis Healthcare Ltd Earnings Release
Metropolis Healthcare Ltd Annual Shareholders Meeting
Similar to METROPOLIS
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Dr. Lal PathLabs
National Stock Exchange of India
FAQ
What is the Metropolis Healthcare share price?
As of Today at 19:14 UTC, shares in Metropolis Healthcare are trading at IN₹1,739.65. This share price information is delayed by 15 minutes.
How has the Metropolis Healthcare share price performed this year?
Shares in Metropolis Healthcare last closed at IN₹1,739.65 and the price had moved by +39.94% over the past 365 days. In terms of relative price strength the Metropolis Healthcare share price has outperformed the S&P BSE 100 Index by +8.54% over the past year.
What are the analyst and broker recommendations for Metropolis Healthcare?
There is no consensus recommendation for this security.
What is the Metropolis Healthcare dividend yield?
The Metropolis Healthcare dividend yield is 0.23% based on the trailing twelve month period.
Does Metropolis Healthcare pay a dividend?
Last year, Metropolis Healthcare paid a total dividend of IN₹4.00, and it currently has a trailing dividend yield of 0.23%. We do not have any data on when Metropolis Healthcare is to next pay dividends.
When does Metropolis Healthcare next pay dividends?
We do not have data on when Metropolis Healthcare is to next pay dividends. The historic dividend yield on Metropolis Healthcare shares is currently 0.23%.
How do I buy Metropolis Healthcare shares?
To buy shares in Metropolis Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Metropolis Healthcare?
As of the previous close price of IN₹1,739.65, shares in Metropolis Healthcare had a market capitalisation of IN₹89.12bn.
Where are Metropolis Healthcare shares listed?
Here are the trading details for Metropolis Healthcare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: METROPOLIS
What kind of share is Metropolis Healthcare?
Based on an overall assessment of its quality, value and momentum Metropolis Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Metropolis Healthcare share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Metropolis Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Metropolis Healthcare. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -1.34%.
As of the last closing price of IN₹1,739.65, shares in Metropolis Healthcare were trading +11.77% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Metropolis Healthcare PE Ratio?
The Metropolis Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1,739.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Metropolis Healthcare?
Metropolis Healthcare's management team is headed by:
- Sushil Shah - CHM
- Vijender Singh - CEO
- Danish Allana - CCO
- Ameera Shah - MDR
- Hemant Sachdev - NED